Login / Signup

Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better.

Hui Jing HoeBenjamin J Solomon
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
  • epidermal growth factor receptor
  • wild type
  • metastatic breast cancer
  • tyrosine kinase